Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors.

Raya AlmazroueiBachar AfandiFatima AlKindiRomona GovenderSaif Al-Shamsi

Published in: Clinical medicine insights. Endocrinology and diabetes (2023)

SGLT2i related DKA is associated with lower blood glucose levels, lower SBP, worse hypovolemia, increased risk of AKI, and longer hospital stay when compared to non SGLT2i related episodes. Since the benefits of SGLT2 inhibitors far outweigh potential risks, there is a need to raise healthcare professionals and patients' awareness about this potential association.

Keyphrases

blood glucose
end stage renal disease
human health
newly diagnosed
ejection fraction
type diabetes
chronic kidney disease
glycemic control
acute kidney injury
healthcare
prognostic factors
peritoneal dialysis
metabolic syndrome
patient reported outcomes
skeletal muscle
drug induced